Basilea Pharmaceutica AG Stock Forecast
Basilea Pharmaceutica AG stock price up more than 5.28% on Wednesday
(Updated on May 08, 2024)
The Basilea Pharmaceutica AG stock price gained 5.28% on the last trading day (Wednesday, 8th May 2024), rising from 40.70 Fr to 42.85 Fr. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 7.21% from a day low at 40.20 Fr to a day high of 43.10 Fr. The price has risen in 6 of the last 10 days and is up by 3.88% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 45 thousand more shares were traded than the day before. In total, 62 thousand shares were bought and sold for approximately 2.65 Fr million.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 16.95% during the next 3 months and, with a 90% probability hold a price between 44.71 Fr and 53.43 Fr at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
BSLN.SW Signals & Forecast
The Basilea Pharmaceutica AG stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at 40.42 Fr and 39.58 Fr. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, April 04, 2024, and so far it has fallen -0.695%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Basilea Pharmaceutica AG stock
On the downside, the stock finds support just below today's level from accumulated volume at 36.50 Fr and 35.90 Fr. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Basilea Pharmaceutica AG finds support just below today's level at 36.50 Fr. If this is broken, then the next support from accumulated volume will be at 35.90 Fr and 35.15 Fr.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved 2.90 Fr between high and low, or 7.21%. For the last week the stock has had daily average volatility of 3.05%.
Our recommended stop-loss: 41.19 Fr (-3.88%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 23 days ago.)
Trading Expectations (BSLN.SW) For The Upcoming Trading Day Of Friday 10th
For the upcoming trading day on Friday, 10th we expect Basilea Pharmaceutica AG to open at 42.05 Fr, and during the day (based on 14 day Average True Range), to move between 41.66 Fr and 44.04 Fr, which gives a possible trading interval of +/-1.19 Fr (+/-2.79%) up or down from last closing price. If Basilea Pharmaceutica AG takes out the full calculated possible swing range there will be an estimated 5.57% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at 43.15 Fr (0.70%) than the support at 36.50 Fr (14.82%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Basilea Pharmaceutica AG stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Basilea Pharmaceutica AG stock to perform well in the short-term.
Current score: 3.947 Buy Candidate Unchanged
Predicted Opening Price for Basilea Pharmaceutica AG of Friday, May 10, 2024
| Fair opening price May 10, 2024 | Current price |
|---|---|
| 42.05 Fr ( 1.87%) | 42.85 Fr |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for BSLN.SW
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 44.95 | 4.90 % | |
| R2 | 43.84 | 2.32 % | ||
| R1 | 43.16 | 0.718 % | ||
| Current price: | 42.85 | |||
| Support | S1 | 40.94 | -4.45 % | |
| S2 | 40.26 | -6.05 % | ||
| S3 | 39.15 | -8.63 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0 | . | |
| R2 | 0 | . | ||
| R1 | 43.15 | 0.700 % | ||
| Current price | 42.85 | |||
| Support | S1 | 36.50 | -14.82% | |
| S2 | 35.90 | -16.22% | ||
| S3 | 35.15 | -17.97% |
BSLN Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Feb 07, 2013 | Apr 11, 2013 | Jun 21, 2013 | 5.00 Fr | 7.43% |
FAQ
Click here for our free guide on how to buy Basilea Pharmaceutica AG Stock.
